World Sleep Industry ENCYCLOPEDIA

Suanzaoren Foot Patches

3.2.2

Definition, Construction, and Category Boundaries

A suanzaoren foot patch is an external product that places powdered Ziziphi Spinosae Semen, an extract, or a multi-ingredient formula containing it in an absorbent pad, nonwoven sachet, or pressure-sensitive adhesive assembly fixed to intact plantar skin. A common construction includes a backing, formulation core, contact layer, adhesive border, and release liner, sometimes with separate fixing tape. Placement on a foot does not make the product a drug patch, and the presence of suanzaoren does not show that its constituents cross skin at a controlled dose.

This category should be distinguished from oral suanzaoren crude material, granules, and capsules; validated transdermal drug-delivery systems; raised-point acupressure patches; warming foot patches; moxibustion patches; exfoliating foot peels; and wound dressings. If a product also generates heat, contains a defined drug, pierces skin, or applies electrical stimulation, each added mechanism requires separate assessment. All effects cannot be attributed automatically to suanzaoren.

Placement over the point marketed as Yongquan or another named acupoint describes location only. It does not demonstrate a standardized pressure dose, transdermal dose, or sleep effect. A foot patch may be used as a scented or tactile personal bedtime item, but nighttime use, sweaty soles, or next-morning discoloration cannot establish sedation, insomnia treatment, or removal of harmful substances from the body.

Botanical Identity, Formulation, and Lot Quality

Suanzaoren generally refers to the dried mature seed of Ziziphus jujuba var. spinosa. Product information should identify a verifiable botanical source and plant part, powder or extract form, extraction ratio and solvent, and the actual quantity placed in each patch. Jujube fruit flesh, leaves, jujube-like fragrance, seeds from another Ziziphus species, and a mixed powder containing only a small marker amount are not interchangeable without disclosure. “Ancient suanzaoren formula” does not identify the material or dose.

Raw-material acceptance should cover macroscopic and species identification, foreign matter, moisture, microorganisms, and applicable risks from pesticide residues, heavy metals, and mycotoxins. Because the seed kernel contains oils, rancidity during storage also matters. Chromatographic fingerprints and markers such as spinosin and jujubosides can help compare identity and lots, but a marker alone does not prove the absence of substitution and does not establish clinical performance of a finished foot patch.

The complete formulation also includes absorbent material, fillers, fragrance or essential oil, preservatives, colorants, adhesive, backing, and release liner. Any of these can alter odor, moisture uptake, occlusion, and irritation risk. The finished product requires verification of per-patch content and distribution, dust or liquid migration, seal integrity, stability under sweaty conditions, and shelf life. Passing a raw-herb test does not replace testing of the assembled patch.

Transdermal Delivery, Patch Discoloration, and Mechanistic Reasoning

Several separate steps lie between placing material on skin and producing a systemic effect: release from the formulation, arrival at the skin surface, passage through the skin barrier, sufficient local or systemic exposure, and a reproducible clinical outcome. Plantar keratin, callus, sweat, walking pressure, patch area, and occlusion time can all change contact. Long contact or moist skin does not demonstrate that suanzaoren constituents have reached an effective concentration.

A product that claims transdermal delivery should measure initial content, release, skin flux, residual content, and human exposure separately, and should explain how partial adhesion, edge lift, or formulation migration changes dose. Detecting one chemical marker, observing that a patch remains attached, or using a computer model to predict receptor binding cannot substitute for actual release, pharmacokinetic, and clinical validation.

Brown color, moisture, tackiness, or stronger odor after use can result from sweat, occlusion, absorbent materials, oxidation of plant powder, dyes, and changes in gels or adhesives. Demonstrating capture of a specific “toxin” would require a prespecified analyte, unused and blank patches, an artificial-sweat control, quantitative analysis, and mass balance. A photograph, color intensity, or weight gain alone does not demonstrate detoxification, heavy-metal removal, removal of “dampness,” or clearance of metabolic waste.

Sleep Evidence and Health-Claim Limits

Some randomized trials and evidence syntheses of suanzaoren report signals of short-term improvement in subjective sleep, but they principally studied oral granules, preparations, or formulas, and sample sizes, study quality, and long-term evidence remain limited. Exposure produced after gastrointestinal absorption of an oral product is not the same dosage form as powder held against plantar skin. Oral evidence cannot establish that a foot patch is effective.

A finished-patch sleep trial should define the final formula, per-patch quantity, wear duration, comparator patch, blinding, adherence, objective and subjective sleep outcomes, next-day function, and adverse events. Before-and-after comparisons, testimonials, animal studies, network pharmacology, or molecular docking printed on packaging cannot exclude the effects of bedtime ritual, expectation, odor, plantar sensation, and natural symptom variation.

The patch therefore should not be claimed to sedate, raise melatonin or GABA, prolong deep sleep, treat insomnia, anxiety, or depression, or replace cognitive behavioral therapy for insomnia, medication management, or evaluation of comorbidities such as sleep apnea. Occasional relaxation can be documented as an individual experience. Persistent sleep difficulty, impaired daytime function, loud snoring with gasping, or a mental-health crisis requires assessment directed at the cause.

Label Selection, Initial Use, and Removal

Selection should examine the manufacturer, model, lot, botanical source and plant part, powder or extract form, quantity per patch, all excipients and fragrances, adhesive and backing, application site and maximum wear time, higher-risk users, storage, and expiration. Phrases such as “multi-herb formula,” “far infrared,” “acupoint infusion,” or “one patch while you sleep,” without formulation, delivery, and use conditions, do not support a safety or efficacy judgment.

Before use, inspect the sole and foot margins. Skin should be clean, dry, intact, and normally sensate. Do not cover a blister, wound, drainage, infection, eczema, a deep fissure, or a moist area between the toes. First exposure to a new formulation or adhesive should be observed while awake and while the area can be checked; it should not begin as an unattended overnight trial. Apply the patch flat as labeled without extra tight wrapping, and avoid folding that creates a hard pressure point inside footwear.

Remove the patch promptly for itching, burning, stinging, pain, unusual numbness, swelling, or marked edge lifting. Support the surrounding skin and fold the patch back slowly at a low angle rather than pulling it vertically. Do not reattach a detached patch or use a harsh solvent to remove residue. Inspect the skin after removal and allow it to recover and remain dry before deciding whether another patch is appropriate.

Adhesive, Occlusion, and Higher-Risk Feet

Prolonged occlusion traps sweat and can macerate the stratum corneum. Adhesives, fragrances, preservatives, botanical powder, and colorants can cause irritation or allergy, while mechanical removal can strip superficial skin. Stronger adhesion is not inherently better. Evaluation should consider hold, edge lift, residue, maceration, peel force, and injury after repeated application, rather than only whether the patch remains attached all night.

Diabetic neuropathy can make burning, pain, or skin injury difficult to detect, and impaired circulation can increase the consequences of a foot problem. A person with reduced sensation, a previous foot ulcer, substantial edema, fragile skin, recent foot surgery, or an inability to see the sole or remove the patch should not rely on ordinary consumer labeling for an overnight trial. Individual professional assessment and routine foot inspection are important in these circumstances.

Children, people unable to communicate discomfort, and those with known allergy to Rhamnaceae plants, fragrance, natural rubber, or a specific adhesive also need special caution. If the formulation and systemic exposure are unknown, “external use” cannot guarantee no interaction during pregnancy, breastfeeding, liver or kidney disease, or concurrent sedative use. Generalized hives, swelling of the face or lips, wheeze, breathing difficulty, or systemic illness requires immediate discontinuation and emergency handling.

Outcome Evaluation, Regulatory Identity, and Stop Rules

Evaluation can record the lot, actual wear time, adhered area, sweating, skin response, subjective sleep, awakenings, and next-day function. A study of added botanical effect should use a comparator that matches appearance, odor, absorption, adhesion, and feel but omits the target ingredient, and should prespecify a clinically important difference. Patch color, remaining powder, and one night’s sleep rating cannot independently establish absorption or benefit.

Regulatory identity depends on jurisdiction, ingredients, delivery method, intended use, and claims. A general comfort product, cosmetic, drug-delivery patch, and medical device are subject to different evidence and quality expectations. A raw-material test report does not mean the finished product has been authorized to treat a condition. Claims of transdermal dosing, insomnia treatment, or removal of toxins through the sole demand evidence and compliance well beyond those of an ordinary scented foot patch.

Retire a patch product if the assembly is damaged, contents leak, moisture or mold develops, the seed material smells rancid, adhesive properties change, or skin reactions recur. Persistent insomnia, a nonhealing foot wound, redness with heat and swelling, a change in foot color or temperature, or increasing numbness requires professional assessment rather than a stronger formula or longer wear. At most, a suanzaoren foot patch can be positioned as a removable personal comfort product; “natural,” “drug-free,” and “acupoint” do not make it a risk-free treatment.